Rapid Results

Cytomegalovirus (CMV) IgG Antibody Rapid Test

Rapid detection of IgG antibodies to Cytomegalovirus (CMV) in human serum or plasma.

CE Certified
ISO 13485
Main image of Cytomegalovirus (CMV) IgG Antibody Rapid Test

Why Choose reOpenTest Infectious Disease Kits?

Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.

Fast Screening

Rapid results in just 10-15 minutes.

Easy Sample Collection

Requires only a small serum or plasma sample.

Convenient Testing

Simple to perform in various settings.

Product Overview

The Cytomegalovirus (CMV) IgG Antibody Rapid Test is a qualitative immunoassay for the detection of IgG antibodies to CMV in human serum or plasma. It provides a convenient and efficient method for screening individuals for prior exposure to CMV infection. Results are available within minutes.

Technical Specifications

Detection Target Cytomegalovirus (CMV) IgG antibodies
Sample Type Serum or Plasma
Methodology Immunochromatographic assay (Lateral Flow)
Detection Range Positive/Negative
Reaction Time 10-15 minutes
Storage Conditions 2-30u00b0C
Shelf Life 24 months

Procedure & Interpretation

Step-by-Step Procedure

  1. Collect serum or plasma sample.
  2. Apply sample to the test device.
  3. Wait 10-15 minutes.
  4. Read and interpret the results.

Result Interpretation

Positive Result
Positive: Visible line for IgG indicates a positive result for CMV IgG antibodies, suggesting past infection.
Negative Result
Negative: Only the control line is visible, indicating a negative result.
Invalid Result
Invalid: If the control line is not visible, the test is invalid and should be repeated.

Frequently Asked Questions

A positive CMV IgG antibody test result indicates prior exposure to the Cytomegalovirus. It does not necessarily indicate an active infection.

CMV IgG antibody testing in pregnant women can help determine if they have been previously exposed to CMV. This information can help assess the risk of congenital CMV infection if a primary infection occurs during pregnancy.

Yes, this test is a screening tool, and results should be confirmed with more definitive laboratory methods if necessary. Results should be interpreted within the clinical context of the patient.

Technical Documents

Download product inserts and brochures for detailed information.

No technical documents are available at this time. Please check back soon.

Partner with reOpenTest

Provide your clients and patients with reliable diagnostic solutions.
Contact us today for bulk pricing and distribution opportunities.

Become a Distributor